🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase III trial studies enzalutamide to see how well it wor...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-01-22
Trial ID
NCT01949337
Treatments Being Tested
The purpose of this study is to find out whether talazoparib in combination...
Status
Recruiting
Location
City of Hope
Start Date
2026-05-04
Trial ID
NCT06844383
Treatments Being Tested
Asymptomatic patients with metastatic castrate resistant prostate cancer (m...
Status
Recruiting
Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Start Date
2023-10-04
Trial ID
NCT06059118
Treatments Being Tested
Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy...
Status
Completed
Location
Piedmont Cancer Institute, P.C.
Start Date
2019-12-05
Trial ID
NCT04179396
Treatments Being Tested
The purpose of this study is to assess the efficacy, tolerability, safety, ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-01-25
Trial ID
NCT05114746
Treatments Being Tested
This Phase 2 Open-label Study examines the efficacy, safety, tolerability, ...
Status
Terminated
Location
Yale Cancer Center
Start Date
2018-11-27
Trial ID
NCT03690141
Treatments Being Tested
The overall aim of the trial is to evaluate the safety, tolerability, and p...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2020-03-04
Trial ID
NCT04221542
Treatments Being Tested
The goal of this clinical trial is to learn about the tolerability of telmi...
Status
Recruiting
Location
Dartmouth Health
Start Date
2024-04-22
Trial ID
NCT06168487
Treatments Being Tested
The primary objective is to assess the activity and efficacy of pembrolizum...
Status
Active Not Recruiting
Location
San Francisco VA Medical Center, San Francisco, CA
Start Date
2020-02-20
Trial ID
NCT04104893
Treatments Being Tested
This is an open-label, two-part, phase 1-2 dose-finding study designed to d...
Status
Active Not Recruiting
Location
University of California, San Francisco
Start Date
2020-07-01
Trial ID
NCT04478279
Treatments Being Tested